Right now, I only have the single-end RNA-Seq for the disease and control samples I am studying. I am wondering if there is a good way to evaluate whether the single-end results are acceptable, how comprehensive it is, and whether it is suitable to use rMats in my case? Do you have any suggestions? Thanks!
Hi,
Right now, I only have the single-end RNA-Seq for the disease and control samples I am studying. I am wondering if there is a good way to evaluate whether the single-end results are acceptable, how comprehensive it is, and whether it is suitable to use rMats in my case? Do you have any suggestions? Thanks!